PMN
ProMIS Neurosciences Inc.
9.40$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | +12,241.2% | +55.9% | +24.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +94.8% | -4.6% | -23.4% | +57.7% | +68.7% | +26.4% | +60.1% | +12.0% | -4.4% | -25.6% | +36.6% | – | |
| – | +19.9% | -5.9% | -29.9% | +72.0% | -10.3% | +19.0% | -28.1% | +36.1% | -28.1% | +19.2% | +64.0% | – | |
| – | +53.9% | -5.1% | -26.2% | +63.4% | +35.4% | +24.3% | +36.5% | +15.4% | -8.3% | -19.7% | +41.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | 0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -102.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -102.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -164.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.